When Did The First Covid Vaccines Come Out? | The Real Dates

If you’ve been asking when the first COVID-19 vaccines came out, you’re not alone. People use that phrase to mean different things: the first time a regulator allowed use, the first day shots started outside trials, or the moment most adults could finally book.

This page pins down the dates that usually settle the debate, then shows how to match the right date to what you mean.

These are the early dates most searches are chasing:

• December 2, 2020: The United Kingdom authorized the Pfizer/BioNTech vaccine for use.
• December 8, 2020: The UK began giving the first public doses outside trials.
• December 11, 2020: The U.S. Food and Drug Administration issued the first emergency use authorization for a COVID-19 vaccine (Pfizer-BioNTech).
• December 21, 2020: The European Union moved into its first authorization after the European Medicines Agency’s recommendation.
• December 31, 2020: The World Health Organization listed the Pfizer/BioNTech vaccine for emergency use.

In regular conversation, December 2020 is the clean answer. If you need a date tied to a specific country or a specific meaning of “came out,” the sections below will keep you on firm ground.

What “Came Out” Means In Vaccine Timelines

Vaccine headlines can talk past each other because they’re describing different steps. When you name the step, the date question gets much easier.

Authorization Date

This is the day a national or regional regulator says a vaccine may be used. In late 2020, many places relied on emergency routes, which allow use before full licensure. If you mean “When did it become legal to give?”, this is your date.

First Doses Outside Trials

This is the day vaccination started in clinics outside a research study. It usually comes soon after authorization, once shipments arrive and sites are ready. If you mean “When did people start getting it?”, this is your date.

Broad Eligibility Date

Early rollouts often began with health workers and residents of long-term care. Broader eligibility arrived later as supply increased. If you’re tying the date to a personal memory, you may be thinking of this stage.

To avoid date mix-ups, pair the number with a verb. Write “authorized” if you mean the regulator’s decision. Write “first doses” if you mean the start of shots in clinics. If you see a date tied to “trial results,” that is yet another step. A single word label next to the date keeps December 2020 straight when later boosters and name changes enter the news. That’s handy when different sources cite different dates for the same vaccine, too.

When The First Covid Vaccines Came Out With Dates And Context

Once phase 3 results were in, regulators moved quickly. Here’s how the first widely cited authorizations lined up across large systems and global bodies.

United Kingdom: Authorization And First Public Doses

On December 2, 2020, the UK announced that it had authorized the Pfizer/BioNTech vaccine for use; see UK authorises Pfizer/BioNTech COVID-19 vaccine.

Public vaccination in the UK began on December 8, 2020. That short gap is normal: doses must ship, storage has to be set, and clinics need booked slots.

United States: First FDA Emergency Use Authorization

In the United States, the first emergency authorization arrived on December 11, 2020, when the FDA issued an Emergency Use Authorization for the Pfizer-BioNTech vaccine. The date appears in the agency letter: Pfizer-BioNTech COVID-19 Vaccine EUA Letter of Authorization.

European Union: EU-Wide Authorization After EMA Review

In the EU, the first authorization followed EMA’s recommendation on December 21, 2020. EMA’s dated page EMA recommends first COVID-19 vaccine for authorisation in the EU is the clearest marker for that point in time.

World Health Organization: Emergency Use Listing

WHO issued its first emergency use listing for a COVID-19 vaccine on December 31, 2020. The news release WHO issues its first emergency use validation for a COVID-19 vaccine dates that listing and explains what the listing is meant to do.

You may have seen reports of earlier vaccine authorizations in 2020 in some countries. Many of those announcements were narrower in scope or were made while large phase 3 trial data were still being gathered. That’s why most people land on December 2020 when they ask when the first COVID-19 vaccines came out.

Before you scan the timeline table, pick the claim you want to make. A regulator date answers “When was it allowed to be used here?” A first-dose date answers “When did clinics start giving it?” Those two dates sit close together in December 2020, but they are not the same.

Date Marker	What Happened	How It Relates To “Came Out”
January 2020	Virus sequence was shared publicly.	Not a release date, yet it starts fast design work.
March 2020	Early human trials began for several candidates.	People received candidates, but not as public vaccination.
Summer 2020	Large phase 3 trials started for leading candidates.	This is where regulators later get usable efficacy data.
November 2020	First big phase 3 readouts were announced.	Memorable headlines, but still not authorization.
December 2, 2020	UK authorization for Pfizer/BioNTech.	Fits “came out” as first widely reported authorization.
December 8, 2020	First public doses in the UK.	Fits “came out” as first real-world rollout.
December 11, 2020	First FDA emergency use authorization in the U.S.	Fits “came out” as U.S. regulatory access.
December 21, 2020	EMA recommended the first vaccine for EU authorization.	Fits “came out” as EU-wide authorization timing.
December 31, 2020	WHO issued its first emergency use listing.	Fits “came out” as a global reference marker.

How Vaccines Went From Sequence To Shots In One Year

It’s normal to wonder how vaccines arrived so quickly. A lot of the speed came from groundwork that already existed: prior coronavirus research, early testing of vaccine platforms, and the ability to fund trials and manufacturing at the same time.

Researchers Didn’t Start From Zero

Once the virus sequence was shared, teams could design candidates fast. Many focused on the spike protein, and prior work on SARS and MERS helped shape those choices.

Trials And Review Overlapped

In 2020, phases and regulator review did not always wait for a single finish line. Data were reviewed in chunks as they arrived, and enrollment moved quickly because the virus was spreading widely.

Rolling Review In Plain Terms

Instead of waiting for one final submission at the end, regulators can review sections as they come in. It shortens the wait between “data complete” and “decision day,” without removing the need for data.

Logistics Shaped The First Rollouts

Authorization doesn’t put doses in freezers by magic. Early mRNA vaccines needed cold storage and tight handling. That’s why authorizations and first doses can be separated by days.

If you’re writing or debating, it helps to say which date you mean. The table below lines up common questions with the right date type.

What You’re Trying To Answer	Date Type To Use	Where To Verify
When legal use began in a country	Regulator authorization date	Regulator or health ministry announcement
When clinics began vaccinating outside trials	First public dose date	National rollout launch update
When the first U.S. authorization happened	FDA emergency use authorization date	FDA authorization letter and product pages
When the first EU-wide authorization happened	EMA recommendation and EU authorization date	EMA news and EU authorization notices
When a global emergency listing began	WHO emergency use listing date	WHO news releases and listing records
When booking opened for most adults near you	Broad eligibility opening date	Local eligibility announcements and booking portals

Want the first date for your own country? Check two items: the first authorization notice (regulator) and the first launch note (health ministry). When you write the date, add a label like “authorized” or “first doses.”

Common Mix-Ups That Change The Date

Most disagreements come from mixing definitions. Here are the ones that cause the biggest date mix-ups.

Emergency Authorization Vs Full Approval

Late 2020 authorizations often used emergency routes, not full licensure. Later headlines may use “approved” to mean full approval, a new age group, or an updated formula. When you see a new date, check what changed.

Trial Results Vs Rollout

Phase 3 readouts hit the news before regulators authorized use. That gap is why some people remember November 2020, while rollout timelines point to December 2020.

First Anywhere Vs First Where You Live

“First” can mean first anywhere or first in your country. Your local start date can lag the earliest authorizations due to supply and distribution schedules.

One last trap is mixing “first vaccine” (first product) with “first authorization” (first legal use). Some places began with Pfizer-BioNTech; others began later with another brand. Checking which vaccine your area used at launch can explain why a local ‘first’ date doesn’t match the December 2020 markers.

Timeline Recap In Plain Dates

Here’s a copy-ready recap of the early dates that answer the question for most readers:

• December 2, 2020: UK authorization announced for Pfizer/BioNTech.
• December 8, 2020: UK vaccination started outside trials.
• December 11, 2020: FDA issued the first U.S. emergency use authorization for a COVID-19 vaccine (Pfizer-BioNTech).
• December 21, 2020: EMA recommended the first COVID-19 vaccine for EU authorization.
• December 31, 2020: WHO issued its first emergency use listing for a COVID-19 vaccine.

If you need the first date for your own country, use that country’s regulator announcement for authorization and its health ministry rollout note for the first-dose launch. That pair usually clears up the confusion in one minute flat.